14-3-3 proteins; bringing new definitions to scaffolding
Abstract
The 14-3-3 proteins are a part of an emerging family of proteins and protein domains that bind to serine/threonine-phosphorylated residues in a context specific manner, analogous to the Src homology 2 (SH2) and phospho-tyrosine binding (PTB) domains. 14-3-3 proteins bind and regulate key proteins involved in various physiological processes such as intracellular signaling (e.g. Raf, MLK, MEKK, PI-3 kinase, IRS-1), cell cycling (e.g. Cdc25, Wee1, CDK2, centrosome), apoptosis (e.g. BAD, ASK-1) and transcription regulation (e.g. FKHRL1, DAF-16, p53, TAZ, TLX-2, histone deacetylase). In contrast to SH2 and PTB domains, which serve mainly to mediate protein-protein interactions, 14-3-3 proteins in many cases alter the function of the target protein, thus allowing them to serve as direct regulators of their targets. This review focuses on the various mechanisms employed by the 14-3-3 proteins in the regulation of their diverse targets, the structural basis for 14-3-3-target protein interaction with emphasis on the role of 14-3-3 dimerization in target protein binding and regulation and provides an insight on 14-3-3 regulation itself.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The phosphorylated form of MDMX S367 may serve as a 14-3-3 binding site.
“It is noteworthy that phosphorylated S367 of MDMX is a potential 14-3-3 binding site (Tzivion et al, 2001).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Tzivion et al, 2001
The citation lists haven’t been fetched yet
References 129 · Cited by 300
- Authors
- Tzivion, G., Shen, Y. H., & Zhu, J.
- Affiliations
- Texas A&M University System (US)
- Texas A&M Health Science Center (US)
- Corresponding author
- Tzivion, Guri
- ORCID
- Venue
- Oncogene
- Published
- 2001-10-01
- Volume
- 20
- Issue
- 44
- Pages
- 6331-6338
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2006902704
- Cited by
- 300
- References
- 129
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 11 · 2020: 12 · 2019: 7 · 2018: 5 · 2017: 19 · 2016: 10 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 11
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › 14-3-3 protein interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- 14-3-3 proteins, protein scaffolds, serine/threonine phosphorylation, protein-protein interaction, intracellular signaling, cell cycle regulation, apoptosis, transcriptional regulation
- MeSH terms
- Animals, Cell Cycle, Humans, Models, Biological, Phosphorylation, Transcription, Genetic, Tyrosine 3-Monooxygenase, Signal Transduction, Protein Structure, Tertiary, 14-3-3 Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review